ReveraGen BioPharma (United States)
Open Access statistics for ReveraGen BioPharma (United States), United States, covering academic research published from 2012 to 2024.
Open Access statistics for ReveraGen BioPharma (United States), United States, covering academic research published from 2012 to 2024. Read More.
Open Access Percentage
75%
Total
Publications
51
Total Open
Publications
38
Total
Citations
1.2K
Open Access
Percentage
75%
Total
Publications
51
Total Open
Publications
38
Total
Citations
1.2K
Breakdown
Publisher Open
12%
Both
45%
Other Platform Open
18%
Closed
25%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 35%
10
Hybrid 34%
10
No Guarantees 31%
9
Other Platform Open
Domain 97%
31
Institution 28%
9
Public 9%
3
Other Internet 3%
1
Preprint 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 31 |
Europe PMC | Domain | 19 |
Newcastle Univesity - Newcastle University ePrints | Institution | 4 |
University of Edinburgh - Edinburgh Research Explorer | Institution | 3 |
Semantic Scholar | Public | 3 |
Radboud University - Radboud Repository | Institution | 2 |
University of Padua - Padua Research Archive | Institution | 1 |
University of California - eScholarship University of California | Institution | 1 |
unimelb.edu.au OAI-PMH Repository | Institution | 1 |
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI | Institution | 1 |